Hyperglycemia - Exposure Details | CTD
Skip navigation

Disease Hyperglycemia

These are exposure details associated with the disease and all of its children.



1–50 of 362 results.
  Reference Exposure Stressor Number of Receptors Receptors Receptor Notes Medium Exposure Marker Marker Level Measurement Statistic Assay Notes Country Outcome Relationship Disease Phenotype
1. Feng W, et al. (2015). Aluminum 2,242 Subjects with disease:Glucose Intolerance Subjects with Diabetes, impaired fasting glucose status or normal glucose tolerance urine China no correlation Diabetes Mellitus
2. Feng W, et al. (2015). Aluminum 2,242 Subjects with disease:Diabetes Mellitus Subjects with Diabetes, impaired fasting glucose status or normal glucose tolerance urine China prediction/hypothesis Glucose Intolerance
3. Feng W, et al. (2015). Aluminum 2,242 Subjects with disease:Glucose Intolerance Subjects with Diabetes, impaired fasting glucose status or normal glucose tolerance urine China prediction/hypothesis abnormal glucose metabolic process
4. Feng W, et al. (2015). Aluminum 2,242 Controls for disease:Glucose Intolerance Subjects with Diabetes, impaired fasting glucose status or normal glucose tolerance urine China prediction/hypothesis abnormal glucose metabolic process
5. Feng W, et al. (2015). Aluminum 2,242 Controls for disease:Glucose Intolerance Subjects with Diabetes, impaired fasting glucose status or normal glucose tolerance urine China prediction/hypothesis Glucose Intolerance
6. Feng W, et al. (2015). Aluminum 2,242 Subjects with disease:Glucose Intolerance Subjects with Diabetes, impaired fasting glucose status or normal glucose tolerance urine China prediction/hypothesis Glucose Intolerance
7. Feng W, et al. (2015). Aluminum 2,242 Controls for disease:Glucose Intolerance Subjects with Diabetes, impaired fasting glucose status or normal glucose tolerance urine China no correlation Diabetes Mellitus
8. Feng W, et al. (2015). Antimony 2,242 Controls for disease:Glucose Intolerance Subjects with Diabetes, impaired fasting glucose status or normal glucose tolerance urine China no correlation abnormal glucose metabolic process
9. Feng W, et al. (2015). Antimony 2,242 Subjects with disease:Glucose Intolerance Subjects with Diabetes, impaired fasting glucose status or normal glucose tolerance urine China no correlation Glucose Intolerance
10. Feng W, et al. (2015). Antimony 2,242 Controls for disease:Glucose Intolerance Subjects with Diabetes, impaired fasting glucose status or normal glucose tolerance urine China prediction/hypothesis Diabetes Mellitus
11. Feng W, et al. (2015). Antimony 2,242 Subjects with disease:Glucose Intolerance Subjects with Diabetes, impaired fasting glucose status or normal glucose tolerance urine China no correlation abnormal glucose metabolic process
12. Feng W, et al. (2015). Antimony 2,242 Controls for disease:Glucose Intolerance Subjects with Diabetes, impaired fasting glucose status or normal glucose tolerance urine China no correlation Glucose Intolerance
13. Feng W, et al. (2015). Antimony 2,242 Subjects with disease:Diabetes Mellitus Subjects with Diabetes, impaired fasting glucose status or normal glucose tolerance urine China no correlation Glucose Intolerance
14. Feng W, et al. (2015). Antimony 2,242 Subjects with disease:Glucose Intolerance Subjects with Diabetes, impaired fasting glucose status or normal glucose tolerance urine China prediction/hypothesis Diabetes Mellitus
15. Shapiro GD, et al. (2015). Arsenic 59 Subjects with disease:Glucose Intolerance impaired glucose tolerance cases blood Arsenic 0.7 micrograms per liter geometric mean Canada
16. Feng W, et al. (2015). Arsenic 2,242 Subjects with disease:Glucose Intolerance Subjects with Diabetes, impaired fasting glucose status or normal glucose tolerance urine China prediction/hypothesis Diabetes Mellitus
17. Rhee SY, et al. (2013). Arsenic 672 Subjects with disease:Glucose Intolerance impaired fasting glucose status urine Arsenic 117.6 micrograms per gram creatinine geometric mean Korea, Republic of
18. Feng W, et al. (2015). Arsenic 2,242 Subjects with disease:Glucose Intolerance Subjects with Diabetes, impaired fasting glucose status or normal glucose tolerance urine China no correlation Glucose Intolerance
19. Feng W, et al. (2015). Arsenic 2,242 Subjects with disease:Diabetes Mellitus Subjects with Diabetes, impaired fasting glucose status or normal glucose tolerance urine China no correlation Glucose Intolerance
20. Feng W, et al. (2015). Arsenic 2,242 Controls for disease:Glucose Intolerance Subjects with Diabetes, impaired fasting glucose status or normal glucose tolerance urine China no correlation abnormal glucose metabolic process
21. Feng W, et al. (2015). Arsenic 2,242 Controls for disease:Glucose Intolerance Subjects with Diabetes, impaired fasting glucose status or normal glucose tolerance urine China no correlation Glucose Intolerance
22. Feng W, et al. (2015). Arsenic 2,242 Subjects with disease:Glucose Intolerance Subjects with Diabetes, impaired fasting glucose status or normal glucose tolerance urine China no correlation abnormal glucose metabolic process
23. Feng W, et al. (2015). Arsenic 2,242 Controls for disease:Glucose Intolerance Subjects with Diabetes, impaired fasting glucose status or normal glucose tolerance urine China prediction/hypothesis Diabetes Mellitus
24. Feng W, et al. (2015). Barium 2,242 Subjects with disease:Diabetes Mellitus Subjects with Diabetes, impaired fasting glucose status or normal glucose tolerance urine China prediction/hypothesis Glucose Intolerance
25. Feng W, et al. (2015). Barium 2,242 Subjects with disease:Glucose Intolerance Subjects with Diabetes, impaired fasting glucose status or normal glucose tolerance urine China no correlation abnormal glucose metabolic process
26. Feng W, et al. (2015). Barium 2,242 Subjects with disease:Glucose Intolerance Subjects with Diabetes, impaired fasting glucose status or normal glucose tolerance urine China prediction/hypothesis Glucose Intolerance
27. Feng W, et al. (2015). Barium 2,242 Subjects with disease:Glucose Intolerance Subjects with Diabetes, impaired fasting glucose status or normal glucose tolerance urine China no correlation Diabetes Mellitus
28. Feng W, et al. (2015). Barium 2,242 Controls for disease:Glucose Intolerance Subjects with Diabetes, impaired fasting glucose status or normal glucose tolerance urine China no correlation abnormal glucose metabolic process
29. Feng W, et al. (2015). Barium 2,242 Controls for disease:Glucose Intolerance Subjects with Diabetes, impaired fasting glucose status or normal glucose tolerance urine China prediction/hypothesis Glucose Intolerance
30. Feng W, et al. (2015). Barium 2,242 Controls for disease:Glucose Intolerance Subjects with Diabetes, impaired fasting glucose status or normal glucose tolerance urine China no correlation Diabetes Mellitus
31. Shapiro GD, et al. (2015). bisphenol A 1,274 Pregnant females entire cohort urine bisphenol A Canada no correlation Glucose Intolerance
32. Shapiro GD, et al. (2015). bisphenol A 59 Subjects with disease:Glucose Intolerance impaired glucose tolerance cases urine bisphenol A 0.9 micrograms per liter geometric mean specific gravity-adjusted Canada
33. Feng W, et al. (2015). Cadmium 2,242 Subjects with disease:Diabetes Mellitus Subjects with Diabetes, impaired fasting glucose status or normal glucose tolerance urine China no correlation Glucose Intolerance
34. Barregard L, et al. (2013). Cadmium 590 Subjects with disease:Glucose Intolerance sum of subjects in each quartile used for calculating prevalence of disease risk Sweden no correlation Diabetes Mellitus, Type 2
35. Barregard L, et al. (2013). Cadmium 58 Subjects with disease:Glucose Intolerance incident cases at 5.4 year follow-up urine Cadmium 0.35 micrograms per gram creatinine median Sweden
36. Barregard L, et al. (2013). Cadmium 194 Controls for disease:Glucose Intolerance urine Cadmium 0.36 micrograms per gram creatinine median Sweden
37. Barregard L, et al. (2013). Cadmium 58 Subjects with disease:Glucose Intolerance incident cases at 5.4 year follow-up blood Cadmium 1.26 micrograms per liter 95th percentile Sweden
38. Barregard L, et al. (2013). Cadmium 118 Controls for disease:Glucose Intolerance urine Cadmium 0.85 micrograms per gram creatinine 95th percentile Sweden
39. Barregard L, et al. (2013). Cadmium 207 Subjects with disease:Glucose Intolerance urine Cadmium 1.03 micrograms per gram creatinine 95th percentile Sweden
40. Feng W, et al. (2015). Cadmium 2,242 Controls for disease:Glucose Intolerance Subjects with Diabetes, impaired fasting glucose status or normal glucose tolerance urine China no correlation abnormal glucose metabolic process
41. Barregard L, et al. (2013). Cadmium 118 Controls for disease:Glucose Intolerance blood Cadmium 0.32 micrograms per liter median Sweden
42. Feng W, et al. (2015). Cadmium 2,242 Subjects with disease:Glucose Intolerance Subjects with Diabetes, impaired fasting glucose status or normal glucose tolerance urine China no correlation Diabetes Mellitus
43. Barregard L, et al. (2013). Cadmium 194 Controls for disease:Glucose Intolerance urine Cadmium 0.92 micrograms per gram creatinine 95th percentile Sweden
44. Barregard L, et al. (2013). Cadmium 118 Controls for disease:Glucose Intolerance urine Cadmium 0.36 micrograms per gram creatinine median Sweden
45. Barregard L, et al. (2013). Cadmium 118 Controls for disease:Glucose Intolerance blood Cadmium 0.17 micrograms per liter 5th percentile Sweden
46. Barregard L, et al. (2013). Cadmium 58 Subjects with disease:Glucose Intolerance incident cases at 5.4 year follow-up blood Cadmium 0.14 micrograms per liter 5th percentile Sweden
47. Barregard L, et al. (2013). Cadmium 590 Controls for disease:Glucose Intolerance sum of subjects in each quartile used for calculating prevalence of disease risk Sweden no correlation Diabetes Mellitus, Type 2
48. Barregard L, et al. (2013). Cadmium 207 Subjects with disease:Glucose Intolerance blood Cadmium 0.14 micrograms per liter 5th percentile Sweden
49. Barregard L, et al. (2013). Cadmium 590 Controls for disease:Glucose Intolerance sum of subjects in each quartile used for calculating prevalence of disease risk Sweden no correlation Glucose Intolerance
50. Shapiro GD, et al. (2015). Cadmium 59 Subjects with disease:Glucose Intolerance impaired glucose tolerance cases blood Cadmium 0.2 micrograms per liter geometric mean Canada
1–50 of 362 results.